The DOI matches its Crossref record.
Control of Jaundice in Preterm Newborns by an Inhibitor of Bilirubin Production: Studies With Tin-Mesoporphyrin
Abstract
Background. Studies in vitro, in animal models, and in adult and newborn humans have demonstrated that certain tin(Sn)-porphyrins that competitively inhibit the activity of heme oxygenase, the rate-limiting enzyme in heme catabolism, reduce production of bilirubin and can thereby substantially diminish plasma levels of the bile pigment. Objectives. To assess the effectiveness of increasing doses of the heme oxygenase inhibitor, Sn-mesoporphyrin (SnMP), in moderating the development of significant hyperbilirubinemia and thus the requirements for phototherapy in preterm newborns. Methods. In five randomized, blinded, placebo-controlled trials, SnMP in increasing doses from 1 µmol to 6 µmol/kg body weight was administered intramuscularly in the first 24 hours of life in preterm newborns of 210 to 251 days gestational age. "Special blue" lamps (Phillips F20T12/BB) were used for phototherapy in newborns exceeding a predetermined plasma bilirubin concentration, irrespective of study group. Results. A total of 517 newborns were randomized in the five trials carried out sequentially over a 4-year period. SnMP in a dose-related manner significantly ameliorated the course of hyperbilirubinemia in the treated newborns Of all gestational ages. With a SnMP dose of 6 µmol/kg body weight, the mean peak incremental plasma bilirubin concentration was reduced by 41% and the phototherapy requirements were decreased by 76% compared to control subjects. Erythema observed in a few SnMP-treated newborns who required phototherapy was mild, transient, and without sequelae. No other untoward effects were observed during hospitalization or at a follow-up at post-term age of 3 and 18 months. Conclusions. SnMP, by inhibiting the production of bilirubin, substantially moderates the development of hyperbilirubinemia in preterm newborns. This compound and similarly acting enzyme inhibitors merit further clinical study as agents for controlling neonatal hyperbilirubinemia, particularly in neonatal populations for whom other treatment modalities are not available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Pharmacological and Clinical Aspects of Heme Oxygenase
Abraham, N. G., & Kappas, A. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.07104 · Cited by 1,115
“The results of extensive randomized clinical trials using SnPP and SnMP in particular to control neonatal jaundice (Valaes et al., 1994) indicate that the use of SnMP within 24 h of birth in premature newborns substantially moderates the development of hyperbilirubinemia and markedly reduces the…”
Self-citationPhototherapy for Neonatal Jaundice
Maisels, M. J., & McDonagh, A. F. (2008) · New England Journal of Medicine · doi:10.1056/nejmct0708376 · Cited by 654
Dennery, P. A., Seidman, D. S., & Stevenson, D. K. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102223440807 · Cited by 598
MULTIDIMENSIONAL FAMILY THERAPY FOR ADOLESCENT DRUG ABUSE: RESULTS OF A RANDOMIZED CLINICAL TRIAL
Liddle, H. A., Dakof, G. A., Parker, K., Diamond, G. S., Barrett, K., & Tejeda, M. (2001) · The American Journal of Drug and Alcohol Abuse · doi:10.1081/ada-100107661 · Cited by 543
Abraham, N. G., Lavrovsky, Y., Schwartzman, M. L., Stoltz, R. A., Levere, R. D., Gerritsen, M. E., Shibahara, S., & Kappas, A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6798 · Cited by 338
Self-citationAn improved discrete bat algorithm for symmetric and asymmetric Traveling Salesman Problems
Osaba, E., Yang, X.-S., Diaz, F., Lopez-Garcia, P., & Carballedo, R. (2016) · Engineering Applications of Artificial Intelligence · doi:10.1016/j.engappai.2015.10.006 · Cited by 312
Cytoprotective Effects of Heme Oxygenase in Acute Renal Failure
Akagi, R., Takahashi, T., & Sassa, S. (2005) · Contributions to Nephrology · doi:10.1159/000086044 · Cited by 53
Metadata
- Authors
- Valaes, T., Petmezaki, S., Henschke, C., Drummond, G. S., & Kappas, A.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 1994-01-01
- Volume
- 93
- Issue
- 1
- Pages
- 1-11
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W1591048367
- Cited by
- 179
- References
- 0
- FWCI
- 8.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.